Latest Breaking News On - Head of clinical research development - Page 1 : vimarsana.com

Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update

Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPlanegg martinsriedKirsty crameResearch developmentHead of clinical research developmentJapan patent officeNational cancer instituteDevelopment agreementAmerican academy of cancer researchAmerican academyCancer researchImmuno oncology summit europePrime standardChief executive officerExecutive management boardCooperative research

Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate

Pipeline expansion into neoantigens with multiple KRAS mutations as the first targetsAcquired exclusive, worldwide rights to a CD40L-CD28 costimulatory switch proteinData from MDG1015 and multiple TCRs combined with PD1-41BB costimulatory

United statesPamela keckKirsty cramePlanegg martinsriedResearch developmentHead of clinical research developmentAmerican academy of cancer researchNational cancer instituteDevelopment agreementJapan patent officeAmerican academyCancer researchImmuno oncology summit europePrime standardChief executive officerExecutive management board

Medigene AG reports financial results and business update for Q1 2023

Medigene AG reports financial results and business update for Q1 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRaimund gabrielKirsty cramePamela keckCorporate developmentCorporate communicationsAmerican academy of cancer researchNational cancer instituteUs national cancer instituteHead of clinical research developmentMc servicesPrime standardChief executive officerExecutive management boardManagement boardInvestor relations

Freeline Therapeutics : Appoints Michael J Parini as Chief Executive Officer and Reports Second Quarter 2021 Financial Results (Form 6-K)

Freeline Appoints Michael J. Parini as Chief Executive Officer and Reports Second Quarter 2021 Financial Results On track for three programs in the clinic by year end; trial. | August 17, 2021

United statesUnited kingdomCity ofMichael pariniTheresa heggieChris hollowoodDavids arringtonMichaelj pariniCompany or freelineVertex pharmaceuticals incPlatform technologyCompany annual report on formPfizer incAmerican society of geneVertex pharmaceuticalsCompany phase

Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomCity ofDavids arringtonJulie kropCompany or freelineSpark therapeutics incHead of clinical research developmentCompany annual report on formExchange commissionHead of clinical developmentInvestor relations corporate communicationsFreeline therapeutics holdingsTherapeutics holdingsChief medical officerClinical development